RARRES2P4

Across TCGA pan-cancer cohorts, RARRES2P4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RARRES2P4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RARRES2P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RARRES2P4 is over-expressed in tumor.

KIRP and LUSC are the cancer types where RARRES2P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RARRES2P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.109	.003	7	view →
LUSC	All	All	+0.091	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RARRES2P4–KIRP

Open the KIRP breakdown →